Are you looking for lead candidate compounds for your target and do you want your drug discovery program to be more efficient, in terms of both time and cost?
Projects are tailored to your requirements; We provide drug discovery services in the fields of biochemical, biophysical and cellular assay development, lab automation, ultra-High Throughput Screening (uHTS, usually in 1536-well format), High-Content Screening and hit-to-lead biological profiling, in order to find novel leads for drug development.
Furthermore all major read-out modalities are available in-house ensuring rapid generation of high-quality hits. As first CRO we integrated Mass Spectrometry (MALDI-TOF MS) into our uHTS system, thus providing you with the opportunity to run label-based and also label-free assays.
You can either bring your own small molecule library or use our 300K IP-free druglike compound library. Our fully automated robot system can handle small libraries, but also libraries from 2 mln. compounds per screen. As a matter of fact, over the past 10 years we have successfully completed more than 200 screening campaigns.
We are continuously expanding our early drug discovery know-how, compound library and services to add value to our vibrant client network and the pharmaceutical R&D community.
In order to help you accelerate drug discovery for a healthier society.
Interested? Get in touch and we’ll help you accelerate your drug discovery.
Pivot Park Sreening Centre is located at Pivot Park in the Netherlands, because it focuses on pharmaceutical R&D. It is a particularly inspiring campus for open innovation in life sciences.
Cost Effective Screening in 384 and 1536 well plates
Discover the advantages of utilizing both 384 and 1536 well plates in high-throughput screening (HTS). Learn how enhanced flexibility, cost-effectiveness, and adaptability can optimize your research efforts. Partner with us for streamlined data management and a competitive edge in drug discovery.
G2Solutions: funding for innovation in single-cell genomics.
The G2Solutions project, led by Prof. Dr. Ir. Floris Foijer from the UMCG – ERIBA Research Institute, has received funding
We started a program to identify novel hits that inhibit the interaction between the viral spike protein subunit S1 and human angiotensin-converting enzyme 2 (hACE2).
Discovery US 2024 in Boston, November 7-8
Join us at Discovery US and network with us and over 250 industry leaders. We will be there to discuss the latest advancements in ultra-High Throughput Screening, Mass Spectrometry, target identification, validation and HIT optimization.
Is your assay amendable to ultra-High-Throughput Screening?
Seven aspects to consider…
Pivot Park – Banting Building (RE600)
Kloosterstraat 9
5349 AB Oss
The Netherlands
Pivot Park Screening Centre
Building OP
Kloosterstraat 9
5349 AB Oss
The Netherlands
To download this publication we would like to receive your e-mail.
To download this publication we would like to receive your e-mail.
To download this publication we would like to receive your e-mail.
